Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
Cochlear Limited (COH.AX)
AUD123.20
+1.90 (+1.57%)
AU ASX Healthcare Medical - Devices
Address
1 University Avenue 2109
Sydney, NSW, AU
Sydney, NSW, AU
CEO
Diggory William Howitt
Website
cochlear.com
IPO
1995-12-31
ISIN AU000000COH5
Also trades on
Australian Securities Exchange · COH.AX (AUD)
Other OTC · CHEOF (USD)
Other OTC · CHEOY (USD)
Description
Globally, Cochlear Limited specializes in the development and provision of implantable auditory solutions for both children and adults. The company's diverse offerings include advanced cochlear implant systems, upgrades for sound processors, bone conduction devices, and a wide array of accessories and other related items. Established in 1981, its global operations are directed from its headquarters in Sydney, Australia.
Market Cap & Enterprise Value
Merger & Acquisition History
No mergers or acquisitions recorded for this company.
Technical Outlook
Loading outlook…
Loading forecast...
Signal Summary
Loading…
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Each column is computed on that timeframe's candles (1D = daily, 1W ≈ weekly, 1M ≈ monthly), not on the same last day. ▲ bullish · ▼ bearish · — neutral. The Net row counts signals per column; hover any cell (or the indicator name) to see the exact rule behind it.
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
Indicative levels generated algorithmically. Not financial advice.
Risk Profile
Loading risk profile…
Price Chart
AUD123.20
+1.90 (+1.57%)
Loading historical data…
Volume Profile
Loading…
Liquidity & share structure
Average Volume
704.0K
Beta
0.25
Float Shares
65.15M
Free Float %
99.6%
Price Performance
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| +3.18% | +3.19% | +6.91% | -49.50% | -63.99% | -61.44% | -62.98% | -58.97% | -55.73% | -16.50% | +3,426.32% |
Rolling Volatility
Loading…
Drawdown
Loading…
Relative Strength
Loading…
Monthly Returns Heatmap
From
To
Loading…
Annual Monthly Returns
Loading…
Daily Returns Distribution
Loading histogram data…
Revenue flow
Revenue by geography
Revenue by segment
From
To
Revenue composition
From
To
By product
By geography
Financial Statements
Select metrics from the tables below to build your comparison.
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
Price Targets & DCF
Current price
123.20
DCF (Unlevered)
441.91
+258.7%
DCF (Levered)
383.29
+211.1%
DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.
Ratings Trend (MoM)
47% Bullish
| Rating | 2026-05 | Change |
|---|---|---|
| Strong Buy | 3 | 0 |
| Buy | 4 | -1 |
| Hold | 7 | -1 |
| Sell | 1 | 0 |
| Strong Sell | 0 | 0 |
Quality scores
Altman Z-Score
8.06
Safe zone
Piotroski F-Score
5 / 9
Average
MOAT Score
8 / 10
Strong MOAT
Composite Rating
B+
Overall Score
3 / 5
Medium
DCF Score
5 / 5
High
ROE Score
5 / 5
High
ROA Score
5 / 5
High
D/E Score
2 / 5
Medium
P/E Score
1 / 5
Low
P/Book Score
1 / 5
Low
Operational MOAT
✗ Below peers
-
Revenue growth Medical - Devices: +11.2%+4.8% Q4'25: +5.6% (vs Q4'23)
-
EPS growth Medical - Devices: +28.5%+9.4% Q4'25: -15.5% (vs Q4'23)
-
FCF margin FCF growth · Medical - Devices: +30.9%+6.4% Q4'25: +9.3% (vs Q4'23)
-
EBIT margin Medical - Devices: +6.2%+22.6% ★ Q4'25: +18.8% (vs Q4'23)
-
ROIC Medical - Devices: +3.3%+20.8% ★ Q4'25: +30.7% (vs Q4'23)
-
Share dilution Medical - Devices: 0.0%-0.4% ★ Q4'25: -0.3% (vs Q4'23)
-
Debt / EBITDA Net debt/EBITDA · Medical - Devices: -0.35×0.38× Q4'25: 0.39× (vs Q4'23)
Valuation Multiples
From
To
Price Forecast (3Y)
From
To
Theoretical Return — If Invested Today
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
Consensus Estimates
| Metric |
Jun 2001 actual |
Jun 2002 actual |
Jun 2003 actual |
Jun 2004 actual |
Jun 2005 actual |
Jun 2006 actual |
Jun 2007 actual |
Jun 2008 actual |
Jun 2009 actual |
Jun 2010 actual |
Jun 2011 actual |
Jun 2012 actual |
Jun 2013 actual |
Jun 2014 actual |
Jun 2015 actual |
Jun 2016 actual |
Jun 2017 actual |
Jun 2018 actual |
Jun 2019 actual |
Jun 2020 actual |
Jun 2021 actual |
Jun 2022 actual |
Jun 2023 actual |
Jun 2024 actual |
Jun 2025 actual |
Jun 2026 15 Rev. Ana. 12 EPS Ana. |
Jun 2027 15 Rev. Ana. 12 EPS Ana. |
Jun 2028 14 Rev. Ana. 9 EPS Ana. |
Jun 2029 10 Rev. Ana. 3 EPS Ana. |
Jun 2030 7 Rev. Ana. 4 EPS Ana. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue |
220.11M
est: 199.98M (+10.1%)
|
254.98M
est: 269.04M (-5.2%)
|
288.58M
est: 318.84M (-9.5%)
|
282.77M
est: 271.15M (+4.3%)
|
344.85M
est: 339.68M (+1.5%)
|
452.26M
est: 457.08M (-1.1%)
|
559.41M
est: 561.20M (-0.3%)
|
601.73M
est: 612.11M (-1.7%)
|
694.70M
est: 698.35M (-0.5%)
|
734.80M
est: 729.53M (+0.7%)
|
809.65M
est: 798.84M (+1.4%)
|
779.00M
est: 778.92M (+0.0%)
|
752.72M
est: 729.75M (+3.1%)
|
804.94M
est: 818.91M (-1.7%)
|
925.63M
est: 938.66M (-1.4%)
|
1.13B
est: 1.14B (-0.9%)
|
1.25B
est: 1.22B (+2.4%)
|
1.36B
est: 1.38B (-1.0%)
|
1.43B
est: 1.46B (-2.2%)
|
1.35B
est: 1.26B (+7.7%)
|
1.49B
est: 1.49B (+0.3%)
|
1.64B
est: 1.64B (+0.1%)
|
1.94B
est: 1.85B (+4.6%)
|
2.24B
est: 2.28B (-1.9%)
|
2.34B
est: 2.37B (-1.3%)
|
2.34B
2.19B – 2.42B
-1.6% YoY
|
2.43B
2.34B – 2.58B
+4.0% YoY
|
2.60B
2.60B – 2.61B
+7.2% YoY
|
2.97B
2.82B – 3.11B
+14.0% YoY
|
2.53B
2.40B – 2.65B
-14.9% YoY
|
| EBITDA |
50.19M
est: 43.99M (+14.1%)
|
56.93M
est: 62.56M (-9.0%)
|
80.81M
est: 60.44M (+33.7%)
|
57.52M
est: 68.03M (-15.5%)
|
91.22M
est: 60.01M (+52.0%)
|
131.30M
est: 99.48M (+32.0%)
|
172.89M
est: 136.53M (+26.6%)
|
190.07M
est: 160.80M (+18.2%)
|
185.30M
est: 172.99M (+7.1%)
|
221.77M
est: 177.26M (+25.1%)
|
243.80M
est: 218.34M (+11.7%)
|
94.13M
est: 224.27M (-58.0%)
|
194.92M
est: 63.61M (+206.4%)
|
154.27M
est: 186.84M (-17.4%)
|
236.96M
est: 124.70M (+90.0%)
|
296.56M
est: 226.54M (+30.9%)
|
347.56M
est: 263.26M (+32.0%)
|
383.20M
est: 338.32M (+13.3%)
|
409.30M
est: 346.80M (+18.0%)
|
-181.90M
est: 318.96M (-157.0%)
|
451.90M
est: -303.40M (+248.9%)
|
475.40M
est: -348.41M (+236.4%)
|
487.10M
est: -368.16M (+232.3%)
|
579.50M
est: -409.87M (+241.4%)
|
619.90M
est: 645.57M (-4.0%)
|
638.79M
599.03M – 660.84M
-1.1% YoY
|
664.58M
638.97M – 706.11M
+4.0% YoY
|
712.41M
710.52M – 714.30M
+7.2% YoY
|
811.85M
771.13M – 851.45M
+14.0% YoY
|
690.81M
656.16M – 724.51M
-14.9% YoY
|
| EBIT |
46.67M
est: 43.99M (+6.1%)
|
52.18M
est: 62.56M (-16.6%)
|
80.81M
est: 60.44M (+33.7%)
|
48.06M
est: 68.03M (-29.4%)
|
77.79M
est: 59.26M (+31.3%)
|
115.23M
est: 98.04M (+17.5%)
|
155.78M
est: 134.31M (+16.0%)
|
168.74M
est: 158.15M (+6.7%)
|
185.12M
est: 172.99M (+7.0%)
|
221.76M
est: 192.15M (+15.4%)
|
243.80M
est: 240.24M (+1.5%)
|
78.31M
est: 234.21M (-66.6%)
|
179.52M
est: 71.67M (+150.5%)
|
127.42M
est: 200.76M (-36.5%)
|
206.71M
est: 147.98M (+39.7%)
|
263.07M
est: 251.12M (+4.8%)
|
316.34M
est: 281.11M (+12.5%)
|
349.00M
est: 353.50M (-1.3%)
|
370.80M
est: 370.28M (+0.1%)
|
-260.60M
est: 326.91M (-179.7%)
|
375.50M
est: -284.12M (+232.2%)
|
402.40M
est: -326.26M (+223.3%)
|
406.00M
est: -344.76M (+217.8%)
|
494.00M
est: -383.81M (+228.7%)
|
529.50M
est: 544.57M (-2.8%)
|
538.85M
505.30M – 557.44M
-1.1% YoY
|
560.60M
539.00M – 595.63M
+4.0% YoY
|
600.95M
599.35M – 602.54M
+7.2% YoY
|
684.83M
650.48M – 718.23M
+14.0% YoY
|
582.72M
553.50M – 611.15M
-14.9% YoY
|
| Net Income |
31.18M
est: 28.03M (+11.2%)
|
40.11M
est: 41.97M (-4.4%)
|
58.21M
est: 47.52M (+22.5%)
|
627.0K
est: 49.49M (-98.7%)
|
1.17M
est: 46.10M (-97.5%)
|
80.03M
est: 71.34M (+12.2%)
|
100.13M
est: 98.76M (+1.4%)
|
115.23M
est: 110.32M (+4.5%)
|
130.54M
est: 127.18M (+2.6%)
|
155.15M
est: 136.80M (+13.4%)
|
180.11M
est: 169.94M (+6.0%)
|
56.80M
est: 175.61M (-67.7%)
|
132.56M
est: 53.21M (+149.1%)
|
93.71M
est: 148.80M (-37.0%)
|
145.84M
est: 109.09M (+33.7%)
|
188.92M
est: 177.44M (+6.5%)
|
223.62M
est: 202.23M (+10.6%)
|
245.80M
est: 250.47M (-1.9%)
|
276.70M
est: 261.24M (+5.9%)
|
-238.30M
est: 244.41M (-197.5%)
|
326.50M
est: -258.22M (+226.4%)
|
289.10M
est: -296.52M (+197.5%)
|
300.60M
est: 300.60M (+0.0%)
|
356.80M
est: 356.80M (+0.0%)
|
388.90M
est: 404.66M (-3.9%)
|
299.70M
274.63M – 324.76M
-25.9% YoY
|
327.49M
296.62M – 389.12M
+9.3% YoY
|
379.00M
347.13M – 423.23M
+15.7% YoY
|
466.90M
436.46M – 496.51M
+23.2% YoY
|
492.75M
460.62M – 523.99M
+5.5% YoY
|
| SGA |
82.85M
est: 72.71M (+13.9%)
|
87.92M
est: 101.44M (-13.3%)
|
107.00M
est: 104.17M (+2.7%)
|
108.36M
est: 90.99M (+19.1%)
|
127.27M
est: 141.94M (-10.3%)
|
154.76M
est: 174.74M (-11.4%)
|
179.68M
est: 191.09M (-6.0%)
|
192.58M
est: 198.05M (-2.8%)
|
230.21M
est: 212.62M (+8.3%)
|
227.43M
est: 241.31M (-5.8%)
|
239.94M
est: 249.00M (-3.6%)
|
242.52M
est: 233.92M (+3.7%)
|
240.94M
est: 227.19M (+6.1%)
|
278.87M
est: 270.33M (+3.2%)
|
320.35M
est: 324.72M (-1.3%)
|
403.43M
est: 389.75M (+3.5%)
|
432.40M
est: 433.94M (-0.4%)
|
494.40M
est: 481.75M (+2.6%)
|
545.70M
est: 525.46M (+3.9%)
|
563.80M
est: 482.02M (+17.0%)
|
560.20M
est: 610.92M (-8.3%)
|
657.70M
est: 701.55M (-6.2%)
|
810.40M
est: 741.32M (+9.3%)
|
897.60M
est: 825.29M (+8.8%)
|
939.90M
est: 942.69M (-0.3%)
|
932.79M
874.72M – 964.98M
-1.1% YoY
|
970.44M
933.05M – 1.03B
+4.0% YoY
|
1.04B
1.04B – 1.04B
+7.2% YoY
|
1.19B
1.13B – 1.24B
+14.0% YoY
|
1.01B
958.15M – 1.06B
-14.9% YoY
|
| EPS |
0.60
est: 0.60 (-0.7%)
|
0.77
est: 0.80 (-4.0%)
|
1.10
est: 1.07 (+3.1%)
|
0.68
est: 0.89 (-23.4%)
|
1.00
est: 1.01 (-1.3%)
|
1.47
est: 1.50 (-2.1%)
|
1.83
est: 1.88 (-2.6%)
|
2.08
est: 2.12 (-1.8%)
|
2.34
est: 2.41 (-2.7%)
|
2.76
est: 2.80 (-1.3%)
|
3.18
est: 3.22 (-1.1%)
|
1.00
est: 2.86 (-65.0%)
|
2.33
est: 2.37 (-1.6%)
|
1.65
est: 1.82 (-9.3%)
|
2.56
est: 2.76 (-7.1%)
|
3.31
est: 3.32 (-0.3%)
|
3.90
est: 3.88 (+0.5%)
|
4.28
est: 4.33 (-1.3%)
|
4.81
est: 4.64 (+3.6%)
|
-4.13
est: 2.45 (-268.9%)
|
4.93
est: 3.71 (+32.8%)
|
4.40
est: 4.31 (+2.1%)
|
4.57
est: 4.63 (-1.4%)
|
5.44
est: 6.05 (-10.0%)
|
5.94
est: 6.06 (-2.0%)
|
4.73
4.20 – 4.96
-22.0% YoY
|
5.30
4.53 – 5.95
+12.1% YoY
|
5.88
5.30 – 6.47
+10.9% YoY
|
7.14
6.67 – 7.59
+21.4% YoY
|
7.53
7.04 – 8.01
+5.5% YoY
|
Historical Ratings (3M)
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-29 | B+ | 3/5 | 5/5 | 5/5 | 5/5 | 2/5 | 1/5 | 1/5 |
| 2026-05-28 | B+ | 3/5 | 5/5 | 5/5 | 5/5 | 2/5 | 1/5 | 1/5 |
| 2026-05-27 | B+ | 3/5 | 5/5 | 5/5 | 5/5 | 2/5 | 1/5 | 1/5 |
| 2026-05-26 | B+ | 3/5 | 5/5 | 5/5 | 5/5 | 2/5 | 1/5 | 1/5 |
| 2026-05-25 | B+ | 3/5 | 5/5 | 5/5 | 5/5 | 2/5 | 1/5 | 1/5 |
| 2026-05-22 | B+ | 3/5 | 5/5 | 5/5 | 5/5 | 2/5 | 1/5 | 1/5 |
| 2026-05-21 | B+ | 3/5 | 5/5 | 5/5 | 5/5 | 2/5 | 1/5 | 1/5 |
| 2026-05-20 | B+ | 3/5 | 5/5 | 5/5 | 5/5 | 2/5 | 1/5 | 1/5 |
| 2026-05-19 | B+ | 3/5 | 5/5 | 5/5 | 5/5 | 2/5 | 1/5 | 1/5 |
| 2026-05-18 | B+ | 3/5 | 5/5 | 5/5 | 5/5 | 2/5 | 1/5 | 1/5 |
| 2026-05-15 | B+ | 3/5 | 5/5 | 5/5 | 5/5 | 2/5 | 1/5 | 1/5 |
| 2026-05-14 | B+ | 3/5 | 5/5 | 5/5 | 5/5 | 2/5 | 1/5 | 1/5 |
| 2026-05-13 | B+ | 3/5 | 5/5 | 5/5 | 5/5 | 2/5 | 1/5 | 1/5 |
| 2026-05-12 | B+ | 3/5 | 5/5 | 5/5 | 5/5 | 2/5 | 1/5 | 1/5 |
| 2026-05-11 | B+ | 3/5 | 5/5 | 5/5 | 5/5 | 2/5 | 1/5 | 1/5 |
| 2026-05-08 | B+ | 3/5 | 5/5 | 5/5 | 5/5 | 2/5 | 1/5 | 1/5 |
| 2026-05-07 | B+ | 3/5 | 5/5 | 5/5 | 5/5 | 2/5 | 1/5 | 1/5 |
| 2026-05-06 | B+ | 3/5 | 5/5 | 5/5 | 5/5 | 2/5 | 1/5 | 1/5 |
| 2026-05-05 | B+ | 3/5 | 5/5 | 5/5 | 5/5 | 2/5 | 1/5 | 1/5 |
| 2026-05-04 | B+ | 3/5 | 5/5 | 5/5 | 5/5 | 2/5 | 1/5 | 1/5 |
| 2026-05-01 | B+ | 3/5 | 5/5 | 5/5 | 5/5 | 2/5 | 1/5 | 1/5 |
| 2026-04-30 | B+ | 3/5 | 5/5 | 5/5 | 5/5 | 2/5 | 1/5 | 1/5 |
| 2026-04-29 | B+ | 3/5 | 5/5 | 5/5 | 5/5 | 2/5 | 1/5 | 1/5 |
| 2026-04-28 | B+ | 3/5 | 5/5 | 5/5 | 5/5 | 2/5 | 1/5 | 1/5 |
| 2026-04-27 | B+ | 3/5 | 5/5 | 4/5 | 5/5 | 2/5 | 1/5 | 1/5 |
| 2026-04-24 | B+ | 3/5 | 5/5 | 4/5 | 5/5 | 2/5 | 1/5 | 1/5 |
| 2026-04-23 | B | 3/5 | 5/5 | 4/5 | 5/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-22 | B | 3/5 | 4/5 | 4/5 | 5/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-21 | B | 3/5 | 4/5 | 4/5 | 5/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-20 | B | 3/5 | 4/5 | 4/5 | 5/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-17 | B | 3/5 | 4/5 | 4/5 | 5/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-16 | B | 3/5 | 4/5 | 4/5 | 5/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-15 | B | 3/5 | 4/5 | 4/5 | 5/5 | 1/5 | 1/5 | 1/5 |
Owner Earnings
Owner's Earnings (history)
From
To
Owner alignment
Owner's Earnings TTM
651.25M
OE per share TTM
9.93
Owner's Yield
9.91%
Maintenance CapEx ratio
8.06%
Maint CapEx / Avg PPE
23.9%
Ownership Overview
Ownership breakdown
Ownership breakdown not available.
At a glance
Institutional holders
—
Total invested
—
Insider transactions (90d)
0
Beneficial owners (>5%)
0
Beneficial owners (>5%)
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional ownership trend
Institutional history not available.
Top institutional holders
Top holders not available.
Insider Activity
Insider Activity — Latest Quarter
No insider activity available.
Insider buys vs sells (history)
Insider history not available.
Recent insider transactions
No recent insider transactions.
Executive team
Top executives
EBIT / Employee
106.0K
Shares Outstanding
65.40M
Executive compensation
Executive compensation (annual)
Executive compensation not available.
CEO compensation breakdown
No CEO compensation history available.
Proxy statements
Proxy statements (DEF 14A)
No proxy statements available for this company yet.
Recent SEC filings
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Stuart Sayers | President of Asia Pacific & Latin America | 5M | male |
| Diggory William Howitt | Chief Executive Officer, MD, President & Executive Director | 3M | male |
| Jan Janssen Elec | Chief Technology Officer | 1M | male |
| Sarah Thom | Chief Financial Officer | 469.2K | — |
| Kristina Devon | Vice President of Corporate Strategy & Investor Relations | — | female |
| Rob McGrory | Group General Counsel & Company Secretary | — | male |
| Karen O'Driscoll | Chief Information Officer | — | female |
| Jennifer Hornery | Senior Vice President of Global People & Culture | — | female |
| Jennifer Stevenson | Vice President of Corporate Communications & Brand | — | female |
| Dean Phizacklea | Senior Vice President of Global Strategic Marketing | — | male |
ESG Score History
No data available for this company.
Senate Trading Activity
No Senate trading activity found for this company.
House Trading Activity
No House trading activity found for this company.
Market share among peers
Peer comparison — filtered group (TTM)
Your opinion
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for COH.AX
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
